Olfactory Training As a Treatment for Olfactory Dysfunction Post COVID-19
NCT ID: NCT05384561
Last Updated: 2024-12-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
70 participants
INTERVENTIONAL
2022-05-31
2025-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
A group will train themselves with 4 scents (rose, orange, clove and eucalyptus) and another group with 4 different scents (cheese, coffee, strawberries and lemon). Olfaction sensory evaluation will be performed by using different olfaction tests (Sniffin' Sticks and UPSIT) and complete questionnaires to assess olfactory perception and particularly parosmia and phantosmia.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
● Experimental group (olfactory training)
1. Initial meeting: Each participant will be asked for a session of approximately 1:30 h which will take place in a ventilated room in the laboratory of Dr. Johannes Frasnelli at UQTR. During the hour preceding this evaluation, subjects will be asked not to smoke, eat or drink anything other than water and not to wear perfume. A research assistant will be responsible for completing the various tests. During this meeting, the following tests will be done:
* Data collection (case report form): medical and socio-demographic questionnaire that will be used for data analysis.
* A nasal obstruction criterion scale - NOSE
* A subjective questionnaire on the impact of OD on quality of life - sQOD-NS
* Chemosensory Dysfunction Home Test - TMSC
* The UPSIT 40 test
* The Sniffin' Sticks test
* Test to assess the manifestation of parosmia and phantosmia
* Teaching on the olfactory rehabilitation kit and explanation of the training protocol.
2. Treatment (12 weeks): Following the initial meeting, patients can begin training:
■ Participants will bring their training kit with them following the olfactory evaluation.
3. Final meeting: After 12 weeks of treatment, an appointment will be scheduled with the participant. The olfactory evaluation will be done as described in the initial meeting. During the hour preceding this evaluation, subjects will be asked not to smoke, eat or drink anything other than water and not to wear perfume. A research assistant will be responsible for administering the various tests. During this meeting, the following tests will be done:
* A subjective questionnaire on the impact of OD on quality of life - sQOD-NS
* Chemosensory Dysfunction Home Test - TMSC
* The UPSIT 40 test
* The Sniffin' Sticks test
* Test to assess the manifestation of parosmia and phantosmia
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Chemosensory training group 1
For 12 weeks, morning and evening, smell four odors namely eucalyptol, phenyl ethanol, Orange, and eugenol, for a total of five minutes per session.
Smell training
For 12 weeks, morning and evening, smell four different odors or four odorless substances for a total of five minutes per session.
Chemosensory training group 2
For 12 weeks, morning and evening, smell four odors namely coffee aroma, cheese aroma, strawberries, and limon, for a total of five minutes per session.
Smell training
For 12 weeks, morning and evening, smell four different odors or four odorless substances for a total of five minutes per session.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Smell training
For 12 weeks, morning and evening, smell four different odors or four odorless substances for a total of five minutes per session.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Willing and able to provide written informed consent
* Understand and read the French language
* Have an internet connection and a working email address
Exclusion Criteria
* Be known chronic rhinosinusitis with or without nasal polyposis
* Have received radiotherapy or chemotherapy for Head and Neck Tumors
* Have a diagnosis of Alzheimer's, Parkinson's, multiple sclerosis or any other neurodegenerative disease 5. Have a brain tumor or ENT diagnosis 6. History of naso-sinus surgery; 7. History of traumatic brain injury
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Université du Québec à Trois-Rivières
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Johannes A Frasnelli, PhD
Role: PRINCIPAL_INVESTIGATOR
Université du Québec à Trois-Rivières
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Université du Québec à Trois-Rivières
Trois-Rivières, Quebec, Canada
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Frank Cloutier, PhD
Role: primary
Simon Bérubé, Med Student
Role: backup
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
OTTODC192022JFUQTR
Identifier Type: -
Identifier Source: org_study_id